๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cutaneous toxicities of antiretroviral therapy for HIV: Part II. Nonnucleoside reverse transcriptase inhibitors, entry and fusion inhibitors, integrase inhibitors, and immune reconstitution syndrome

โœ Scribed by Camille E. Introcaso; Janet M. Hines; Carrie L. Kovarik

Book ID
116586799
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
349 KB
Volume
63
Category
Article
ISSN
1097-6787

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Cutaneous toxicities of antiretroviral t
Cutaneous toxicities of antiretroviral therapy for HIV: Part II. Nonnucleoside reverse transcriptase inhibitors, entry and fusion inhibitors, integrase inhibitors, and immune reconstitution syndrome
โœ Camille E. Introcaso; Janet M. Hines; Carrie L. Kovarik ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 349 KB

Cutaneous manifestations of antiretroviral medications for HIV are common and potentially dangerous conditions encountered by dermatologists. Part II of this two-part series on the cutaneous effects of antiretroviral medications for HIV will discuss the four most recent classes of medications that h

Cutaneous toxicities of antiretroviral t
Cutaneous toxicities of antiretroviral therapy for HIV: Part I. Lipodystrophy syndrome, nucleoside reverse transcriptase inhibitors, and protease inhibitors
โœ Camille E. Introcaso; Janet M. Hines; Carrie L. Kovarik ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 660 KB

Antiretroviral medications for the treatment of HIV are common drugs with diverse and frequent skin manifestations. Multiple new cutaneous effects have been recognized in the past decade. Dermatologists play an important role in accurately diagnosing and managing the cutaneous toxicities of these me